CASE SERIES OF NEOVASCULAR GLAUCOMA:EARLY LIMITEDTRANS-SCLERAL CYTOPHOTOCOAGULATIONS (TSCPC) AS AN OPTIONS FOR PREPARATION OF FILTERING SURGERY IN NVG PATIENTS CAN SAVE PATIENT’S VISIONS

Authors

  • Wan Mohd Aiman bin Wan Abdul Rahman Ophthalmology Department, Faculty of medicine, University Malaya, Malaysia
  • Nurull Bahya Suliman Ophthalmology Department, Hospital Tengku Ampuan Rahimah Klang, Malaysia
  • Sujaya Sigh Ophthalmology Department, Faculty of medicine, University Malaya, Malaysia

DOI:

https://doi.org/10.31674/mjmr.2021.v05i02.002%20

Abstract

Neovascular Glaucoma (NVG) is a severe form of secondary glaucoma characterized by proliferation of fibrovascular tissue in the anterior chamber angle. Clinically rubeosis iridis was seen at the pupillary margin and angle via gonioscopy.NVG results in guarded visual prognosis in view of aggressive clinical course and the difficulty in controlling the intraocular pressure(IOP).Patient treatment is indivdualized by taking into account patient visual prognosis, severity, level ofIOP, the cause of NVG, financial issues and patient’s expectations. Trans-scleral cytophotocoagulations is one of the modalities available to reduce the intraocular pressure, usually reserved for the poor prognosis eye in view of its destructive nature . TSCPC in a good prognosis eye is always used in cautions.In this case series, we present 3 case of NVG whichwe use the early limited TSCPC to reduce the IOP to buy time for other managementsin which patient have good visual outcome.

Keywords:

TSCPC in NVG, Neovascular Glaucoma, TSCPC , CPC, Filtering Surgery

Downloads

Download data is not yet available.

References

Fong, A.W., Lee, G.A., O'Rourke, P. & Thomas, R. (2011) Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Clinical & Experimental Ophthalmology, 39(4); pp:318-323.

Moharram, H.M., Abd-ElhamidMehanyElwan, S., Nassar, M.M. & Abdelkader, M.F. (2020) Triple Procedure for Dense Cataractous Neovascular Glaucoma Patients. Journal of Ophthalmology, 2020.

Moraczewski, A.L., Lee, R.K., Palmberg, P.F., Rosenfeld, P.J. & Feuer, W.J. (2009) Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. British Journal of Ophthalmology, 93(5); pp:589-593.

Noor, N.A., Mustafa, S. & Artini, W. (2017) Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience. Clinical Ophthalmology (Auckland, NZ), 11, pp:1417.

Park, U.C., Park, K.H., Kim, D.M. & Yu, H.G. (2011) Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. Journal of Glaucoma, 20(7); pp:433-438.

Takihara, Y., Inatani, M., Fukushima, M., Iwao, K., Iwao, M. & Tanihara, H. (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. American Journal of Ophthalmology, 147(5); pp:912-918.

Yildirim, N., Yalvac, I.S., Sahin, A., Ozer, A. & Bozca, T. (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. Journal of Glaucoma, 18(3); pp:192-196.

Published

2021-04-01

How to Cite

Wan Mohd Aiman bin Wan Abdul Rahman, Nurull Bahya Suliman, & Sujaya Sigh. (2021). CASE SERIES OF NEOVASCULAR GLAUCOMA:EARLY LIMITEDTRANS-SCLERAL CYTOPHOTOCOAGULATIONS (TSCPC) AS AN OPTIONS FOR PREPARATION OF FILTERING SURGERY IN NVG PATIENTS CAN SAVE PATIENT’S VISIONS. Malaysian Journal of Medical Research (MJMR), 5(2), 9-11. https://doi.org/10.31674/mjmr.2021.v05i02.002